Search

Memorial Sloan Kettering Cancer Center (MSK) is pleased to announce TIME has named two MSK physician-scientists, Andrea Cercek, MD, and Vinod Balachandran, MD, to the 2025 TIME100 Health, a list of the 100 most influential individuals in health.

… Thursday, May 8, 2025 Memorial Sloan Kettering Cancer Center (MSK) is pleased to announce TIME has named two MSK physician-scientists, Andrea Cercek, MD , and Vinod Balachandran, MD , to the 2025 TIME100 Health , a list of the 100 most influential individuals in health. Dr. Cercek is recognized for her

Learn about how MSK’s new Lobular Breast Cancer Program is working to improve outcomes for people with invasive lobular breast cancer and other types of LBC.

… Thursday, October 2, 2025 Because lobular breast cancer (LBC) is a type of breast cancer that can be difficult to detect and challenging to treat, it is the focus of a special program at Memorial Sloan Kettering Cancer Center (MSK). Also called invasive lobular carcinoma, it is the second most common

Radiation is a feasible option for patients with squamous cell carcinoma of the anterior nasal cavity mucosa who refuse rhinectomy, according to our recent research.

… Friday, June 7, 2019 Our findings demonstrate that a non-operative approach with high-dose radiotherapy and concurrent chemoradiotherapy can result in favorable outcomes. Marc A. Cohen Associate Chief Medical Officer, Access and Patient Flow; Surgical Director, Pituitary and Skull Base Tumor Center Radiation

Hear from cervical cancer survivor Susan Shaw about how she joined the Empire Dragon Boat Team three years ago and is in the best shape of her life.

… Tuesday, August 21, 2018 Summary This story originally appeared in Bridges, MSK’s newsletter for cancer survivors. Bridges offers a forum in which patients and their families can share stories of inspiration and hope, and of the challenges that can accompany a cancer journey. Learn more about how to

Results to be presented at the upcoming American Society of Clinical Oncology (ASCO) meeting suggest combination immunotherapy may help more people with the most common form of lung cancer.

… Wednesday, June 1, 2016 Summary Immunotherapy has emerged as a promising new treatment option for people with lung cancer . MSK scientists are conducting research to enable more patients to benefit from immunotherapies, at earlier stages. We spoke with MSK lung cancer and immunotherapy expert Matthew

Memorial Sloan Kettering Cancer Center (MSK) has been ranked as the number two hospital for cancer care in the nation, according to U.S. News & World Report in its annual listing of Best Hospitals. Since the inception of the rankings 30 years ago, MSK has held either the first or second spot each year for cancer care. MSK was also ranked first in gynecology.

… Tuesday, July 30, 2019 Memorial Sloan Kettering Memorial Sloan Kettering Cancer Center (MSK) has been ranked as the number two hospital for cancer care in the nation, according to  U.S. News & World Report  in its annual listing of Best Hospitals. Since the inception of the rankings 30 years ago, MSK

Preliminary results of a randomized, international Phase II trial of VEGF Trap (aflibercept) show activity in patients with recurrent epithelial ovarian cancer (EOC) who had received three or four prior chemotherapy regimens and had become resistant to platinum-based chemotherapy agents.

… Saturday, June 2, 2007 Preliminary results of a randomized, international Phase II trial of VEGF Trap (aflibercept) show activity in patients with recurrent epithelial ovarian cancer (EOC) who had received three or four prior chemotherapy regimens and had become resistant to platinum-based chemotherapy

Medical oncologist Ping Chi has been named an incumbent of a Geoffrey Beene Junior Faculty Chair, a position designed to provide funding to outstanding young researchers at a crucial early stage in their careers.

… Thursday, March 1, 2012 Summary Medical oncologist Ping Chi has been named an incumbent of a Geoffrey Beene Junior Faculty Chair, a position designed to provide funding to outstanding young researchers at a crucial early stage in their careers. Ping Chi has been named an incumbent of a Geoffrey Beene

The Society of Memorial Sloan Kettering Cancer Center (MSK), an organization of dedicated volunteers, raised an extraordinary $6.6 million in their 2022–2023 season, fueling innovations in cancer care, research, and education.

… Monday, June 10, 2024 The Society of Memorial Sloan Kettering Cancer Center (MSK), an organization of dedicated volunteers, raised an extraordinary $6.6 million in their 2022–2023 season, fueling innovations in cancer care, research, and education. Infographic text: The Society raised an extraordinary

In this Q&A, medical oncologist Martee Hensley discusses the diagnosis and treatment of leiomyosarcoma and other uterine sarcomas.

… Thursday, July 14, 2016 Summary Memorial Sloan Kettering has a team of experts who specialize in the diagnosis and treatment of uterine sarcomas . Here, medical oncologist Martee Hensley tells us the latest developments in leiomyosarcoma and how our team approach benefits people with these rare cancers